Denver, Colorado - Today’s headlines underscore a decisive shift toward owning the infrastructure, power, and materials that will underpin the next phase of the AI economy.
VCI Global Plants Its Flag in Southeast Asia AI
VCI Global (NASDAQ:VCIG) is accelerating its pivot into AI-native infrastructure, announcing that subsidiary V Gallant has launched Malaysia’s first NVIDIA-powered AI GPU Computing Center as of March 3, 2026. Simultaneously, the company debuted Intelli-X, its enterprise-grade large language model (LLM) platform designed for regulated industries, SMEs, and government agencies.
The move positions VCI as an early AI compute owner-operator in Southeast Asia, a region experiencing surging demand for GPU-intensive workloads amid tightening data governance requirements. Malaysia itself is emerging as a regional AI hub, with projections from InvestKL and the Malaysian Investment Development Authority (MIDA) pointing to more than $40 billion in AI and data center investments by 2030.
With GPU leasing, private clusters, and subscription-based LLM deployment now commercially active, VCI is transitioning from buildout mode to recurring revenue activation, a key milestone in its strategic transformation.
Kraig Biocraft’s Spider Silk Moment
Meanwhile, materials innovation is entering the spotlight.
Kraig Biocraft Laboratories (OTCQB:KBLB) drew fresh attention after its recombinant spider silk technology appeared on the cover of National Geographic’s March 2026 issue. The feature highlighted the company’s genetically enhanced silkworm platform, which produces spider silk fibers as part of the natural silkworm process.
Kraig is preparing to deploy approximately one million proprietary spider silk silkworm eggs across facilities in Vietnam, targeting production of up to 10 metric tons of cocoons per month beginning in March. If sustained, commercial-scale output would mark a rare milestone in transgenic animal platform commercialization, historically associated with ATryn, later incorporated into Sanofi (NASDAQ:SNY) following its acquisition of Genzyme.
With potential applications spanning defense, industrial textiles, and advanced apparel, spider silk’s legendary strength-to-weight properties could intersect with rising global demand for lighter, more durable protective materials.
Can-Fite Advances in Pancreatic Cancer
Can-Fite BioPharma (NYSE:CANF) reported that its Phase IIa study evaluating namodenoson in advanced pancreatic ductal adenocarcinoma met its primary safety endpoint.
The open-label trial enrolled 20 heavily pretreated patients, demonstrating that namodenoson was well tolerated with no new safety signals. One-third of patients were alive at data cutoff, with survival follow-up ongoing. Namodenoson, a selective A3 adenosine receptor agonist, holds FDA Orphan Drug Designation for pancreatic cancer.
While efficacy data will continue to mature, the clean safety profile supports continued development in a notoriously difficult-to-treat cancer setting.
Actelis Rides Smart Transportation Tailwinds
Shares of Actelis Networks (NASDAQ:ASNS) surged following news of a new order supporting a $120 million infrastructure modernization initiative led by the California Department of Transportation (Caltrans) in San Mateo County.
The project adds to a growing list of municipal and state-level transportation wins. Actelis’ hybrid fiber-copper networking devices enable rapid deployment of secure, fiber-grade connectivity over existing copper infrastructure, a cost-efficient solution as agencies modernize traffic systems and edge-AI-enabled roadside networks.
With North American smart transportation demand projected to approach $90 billion in 2026, Actelis continues to deepen its foothold in a digitizing public infrastructure market.
Powering the AI Boom: Babcock & Wilcox Lands $2.4B Notice to Proceed
The AI data center buildout is also reshaping the power generation landscape.
Babcock & Wilcox (NYSE:BW) announced full notice to proceed on a $2.4 billion design-build agreement with Base Electron, an independent power producer backed by Applied Digital (NASDAQ:APLD).
The project will deliver 1.2 gigawatts of new natural gas-fired generation capacity intended to supply Applied Digital AI Factory campuses. Siemens Energy will supply steam turbine generator technology.
The announcement coincided with B&W’s fourth-quarter and full-year 2025 results, which showed adjusted EBITDA more than doubling year over year and backlog surging to $2.8 billion, a 470% increase versus year-end 2024, driven largely by the AI-linked power project.
As hyperscale AI compute demands strain grids nationwide, dispatchable generation assets are quickly becoming strategic infrastructure.
Firefly Scales Toward a Brain Foundation Model
AI’s reach is extending into neuroscience as well.
Firefly Neuroscience (NASDAQ:AIFF) reported a 20-fold expansion of its commercial footprint and a 33-fold increase in EEG/ERP scan volumes following its acquisition of Evoke Neuroscience.
Now partnered with 99 commercial users and leveraging NVIDIA L40S GPU acceleration, Firefly aims to build what it describes as the world’s first EEG/ERP-based foundation model of the human brain, a potentially transformative step in biomarker discovery and neurological disorder treatment.
24/7 Market News encourages readers and industry observers to obtain a copy of this month’s National Geographic to review the full feature and explore the scientific context in depth. Interested persons can order a copy of the magazine from National Geographic at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.
You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering
** Photography by Mark Thiessen, NGM Staff, Image Copyright: National Geographic Magazine
As recombinant biomaterials continue to move from laboratory research toward commercial production, independent coverage from globally recognized science publications reflects growing mainstream attention to the field.
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247marketnews.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider that owns KBLB shares, which are on deposit and may be sold at the editor’s discretion, and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.
For further information, please visit 247marketnews.com or https://go.247marketnews.com/kblb-disclosure/
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
OTCQB:KBLB, NASDAQ:VCIG, NYSE:CANF, NASDAQ:ASNS, NYSE:BW, NASDAQ:APLD